
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Johnson Matthey Plc (JMPLY) Q4 2026 Earnings Call Transcript

Johnson Matthey LON: JMAT reported higher underlying profit, improved margins and stronger cash generation for fiscal 2025/2026, while management outlined progress on a restructuring strategy, the pending sale of Catalyst Technologies and a new acquisition aimed at expanding its emissions-control business.

Johnson Matthey PLC's (LSE:JMAT) full-year results were broadly in line with the upgraded guidance the FTSE 100 specialty chemicals group had already provided, leaving the shares flat in early trading as investors focused instead on the $460 million Cormetech acquisition announced alongside the numbers. Panmure Liberum, which rates the stock a 'buy' with a 2310p target price, described the financial year to March 2027 as set to be "an exciting year" for the group.

British chemicals company Johnson Matthey said on Thursday it would buy Cormetech for $360 million, betting on growth in the U.S. power generation market amid strong demand for emission control at data centres.

Johnson Matthey PLC (LSE:JMAT), the FTSE 100 specialty chemicals group, is acquiring Cormetech, the leading US manufacturer of selective catalytic reduction (SCR) catalysts, for an enterprise value of $360 million in cash. An additional earn-out of up to $100 million may be payable in 2028 and 2029 if Cormetech hits certain financial targets.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Investors with an interest in Chemical - Diversified stocks have likely encountered both Johnson Matthey PLC (JMPLY) and Air Liquide (AIQUY). But which of these two companies is the best option for those looking for undervalued stocks?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Investors interested in stocks from the Chemical - Diversified sector have probably already heard of Johnson Matthey PLC (JMPLY) and Air Liquide (AIQUY). But which of these two companies is the best option for those looking for undervalued stocks?

Enlightify (NYSE: ENFY - Get Free Report) and Johnson Matthey (OTCMKTS:JMPLY - Get Free Report) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk. Valuation and Earnings This table compares Enlightify and

Johnson Matthey (JMPLY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
